Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niccine placebo-controlled phase 2 study for smoking relapse prevention
2007-003250-29Phase 2Completed
- Sponsor
- Independent Pharmaceutica
- Start
- Dec 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial in nicotine dependence comparing Niccine with Placebo (2 arms). Primary endpoint: Smoking relapse prevention at 12 months. Started Dec 2007; status: completed.
02
Drugs
nicotine conjugate vaccine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on 2007-003250-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003250-29.